Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Moon

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Alimentary Pharmacology & Therapeutics|September 20, 2020
Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomesPhilip Vutien, Nicole J Kim, Andrew M Moon, et al.
Journal of Hepatocellular Carcinoma|March 11, 2025
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention TargetsAndrew M Moon, Michael D Kappelman, A Sidney Barritt Iv, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent OutbreaksAndrew M Moon, Elliott Lowy, Marissa M Maier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 3, 2019
Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular CarcinomaKatherine S Cools, Andrew M Moon, Lauren M B Burke, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2024
Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure? Authors' replyPhilip Vutien, Nicole J Kim, Andrew M Moon, et al.
Plos One|December 17, 2021
Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for actionOlufunso M Agbalajobi, Theresa Gmelin, Andrew M Moon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Sex Differences in Liver Cancer Mortality Trends in the US: Role of Cancer Type, Aetiology, and Birth CohortUgo Fedeli, Sara Battistella, Elisa Pinto, et al.
International Journal of Clinical Pharmacy|July 30, 2021
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) dataHuilin Tang, Liyuan Zhou, Xiaotong Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2019
Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV InfectionElliot B Tapper, Neehar D Parikh, Pamela K Green, et al.
Plos One|March 4, 2014
Evaluation of in-hospital management for febrile illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the treatment of malariaAndrew M Moon, Holly M Biggs, Matthew P Rubach, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Alimentary Pharmacology & Therapeutics|September 20, 2020
Fibroscan liver stiffness after anti-viral treatment for hepatitis C is independently associated with adverse outcomesPhilip Vutien, Nicole J Kim, Andrew M Moon, et al.
Journal of Hepatocellular Carcinoma|March 11, 2025
Improving Health-Related Quality of Life in Hepatocellular Carcinoma Patients: Key Methodologies for Assessing Patient Reported Outcomes and Intervention TargetsAndrew M Moon, Michael D Kappelman, A Sidney Barritt Iv, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Hepatitis A Virus Prevention and Vaccination Within and Outside the Veterans Health Administration in Light of Recent OutbreaksAndrew M Moon, Elliott Lowy, Marissa M Maier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 3, 2019
Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular CarcinomaKatherine S Cools, Andrew M Moon, Lauren M B Burke, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2024
Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure? Authors' replyPhilip Vutien, Nicole J Kim, Andrew M Moon, et al.
Plos One|December 17, 2021
Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for actionOlufunso M Agbalajobi, Theresa Gmelin, Andrew M Moon, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 26, 2026
Sex Differences in Liver Cancer Mortality Trends in the US: Role of Cancer Type, Aetiology, and Birth CohortUgo Fedeli, Sara Battistella, Elisa Pinto, et al.
International Journal of Clinical Pharmacy|July 30, 2021
Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) dataHuilin Tang, Liyuan Zhou, Xiaotong Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2019
Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV InfectionElliot B Tapper, Neehar D Parikh, Pamela K Green, et al.
Plos One|March 4, 2014
Evaluation of in-hospital management for febrile illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the treatment of malariaAndrew M Moon, Holly M Biggs, Matthew P Rubach, et al.
Pageof 11